CA Stock MarketDetailed Quotes

INNO InnoCan Pharma Corp

Watchlist
  • 0.245
  • 0.0000.00%
15min DelayTrading Sep 6 11:08 ET
69.99MMarket Cap-11666P/E (TTM)

InnoCan Pharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
53.84%5.19M
12.37%4.6M
-21.47%3.89M
-21.47%3.89M
-37.28%4.02M
-56.34%3.37M
-57.17%4.09M
-55.22%4.95M
-55.22%4.95M
9.38%6.42M
-Cash and cash equivalents
53.84%5.19M
12.37%4.6M
-21.47%3.89M
-21.47%3.89M
-37.28%4.02M
-56.34%3.37M
-57.17%4.09M
-55.22%4.95M
-55.22%4.95M
9.38%6.42M
-Accounts receivable
12.50%18K
6.67%16K
13.33%17K
13.33%17K
-64.41%21K
-46.67%16K
25.00%15K
--15K
--15K
--59K
-Other receivables
88.36%599K
209.78%1.11M
----
----
-11.05%346K
-30.72%318K
26.50%358K
----
----
3.18%389K
Total current assets
49.20%8.59M
42.43%8.91M
-1.08%6.8M
-1.08%6.8M
-18.13%6.73M
-38.65%5.76M
-44.11%6.26M
-45.07%6.88M
-45.07%6.88M
16.56%8.22M
Non current assets
-Long term equity investment
-84.62%4K
-73.08%7K
-45.00%11K
-45.00%11K
-36.00%16K
116.67%26K
85.71%26K
--20K
--20K
--25K
Regulatory assets
-11.75%398K
186.34%922K
185.60%694K
185.60%694K
179.41%475K
81.12%451K
87.21%322K
-74.77%243K
-74.77%243K
30.77%170K
Total assets
--0
218.75%408K
187.59%417K
187.59%417K
123.81%188K
93.14%197K
15.32%128K
--145K
--145K
-1.18%84K
Liabilities
Current liabilities
Current debt and capital lease obligation
----
----
57.14%22K
57.14%22K
----
----
----
--14K
--14K
----
-Current capital lease obligation
----
----
57.14%22K
57.14%22K
----
----
----
--14K
--14K
----
-accounts payable
119.77%389K
65.05%477K
17.89%112K
17.89%112K
139.57%333K
-28.63%177K
87.66%289K
79.25%95K
79.25%95K
61.63%139K
-Total tax payable
-84.62%4K
-73.08%7K
-45.00%11K
-45.00%11K
-36.00%16K
116.67%26K
85.71%26K
--20K
--20K
--25K
Current accrued expenses
----
----
45.60%463K
45.60%463K
----
----
----
--318K
--318K
----
Current liabilities
205.96%2.67M
318.78%4.33M
247.88%2.54M
247.88%2.54M
128.25%2.35M
-62.11%873K
-59.11%1.03M
-79.49%731K
-79.49%731K
-67.48%1.03M
Non current liabilities
-Long term debt
-84.62%4K
-73.08%7K
-45.00%11K
-45.00%11K
-36.00%16K
116.67%26K
85.71%26K
--20K
--20K
--25K
Non current accrued expenses
-14.08%122K
-9.22%128K
38.78%136K
38.78%136K
44.09%134K
77.50%142K
58.43%141K
81.48%98K
81.48%98K
43.08%93K
Total non current liabilities
197.55%2.68M
309.16%4.33M
240.08%2.55M
240.08%2.55M
124.36%2.37M
-61.18%899K
-58.31%1.06M
-78.93%751K
-78.93%751K
-66.69%1.06M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Additional paid-in capital
11.83%39.33M
10.94%38.95M
6.93%37.18M
6.93%37.18M
5.37%36.49M
2.35%35.17M
2.88%35.11M
3.28%34.77M
3.28%34.77M
23.68%34.63M
Retained earnings
2.94%105K
33.01%137K
32.69%138K
32.69%138K
37.14%144K
-6.42%102K
1.98%103K
--104K
--104K
36.36%105K
Other equity interest
--35K
----
----
----
----
----
----
----
----
----
Total equity
47.68%8.72M
41.29%9.04M
-0.52%6.94M
-0.52%6.94M
-17.44%6.87M
-37.66%5.9M
-43.30%6.4M
-44.52%6.98M
-44.52%6.98M
16.80%8.32M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 53.84%5.19M12.37%4.6M-21.47%3.89M-21.47%3.89M-37.28%4.02M-56.34%3.37M-57.17%4.09M-55.22%4.95M-55.22%4.95M9.38%6.42M
-Cash and cash equivalents 53.84%5.19M12.37%4.6M-21.47%3.89M-21.47%3.89M-37.28%4.02M-56.34%3.37M-57.17%4.09M-55.22%4.95M-55.22%4.95M9.38%6.42M
-Accounts receivable 12.50%18K6.67%16K13.33%17K13.33%17K-64.41%21K-46.67%16K25.00%15K--15K--15K--59K
-Other receivables 88.36%599K209.78%1.11M---------11.05%346K-30.72%318K26.50%358K--------3.18%389K
Total current assets 49.20%8.59M42.43%8.91M-1.08%6.8M-1.08%6.8M-18.13%6.73M-38.65%5.76M-44.11%6.26M-45.07%6.88M-45.07%6.88M16.56%8.22M
Non current assets
-Long term equity investment -84.62%4K-73.08%7K-45.00%11K-45.00%11K-36.00%16K116.67%26K85.71%26K--20K--20K--25K
Regulatory assets -11.75%398K186.34%922K185.60%694K185.60%694K179.41%475K81.12%451K87.21%322K-74.77%243K-74.77%243K30.77%170K
Total assets --0218.75%408K187.59%417K187.59%417K123.81%188K93.14%197K15.32%128K--145K--145K-1.18%84K
Liabilities
Current liabilities
Current debt and capital lease obligation --------57.14%22K57.14%22K--------------14K--14K----
-Current capital lease obligation --------57.14%22K57.14%22K--------------14K--14K----
-accounts payable 119.77%389K65.05%477K17.89%112K17.89%112K139.57%333K-28.63%177K87.66%289K79.25%95K79.25%95K61.63%139K
-Total tax payable -84.62%4K-73.08%7K-45.00%11K-45.00%11K-36.00%16K116.67%26K85.71%26K--20K--20K--25K
Current accrued expenses --------45.60%463K45.60%463K--------------318K--318K----
Current liabilities 205.96%2.67M318.78%4.33M247.88%2.54M247.88%2.54M128.25%2.35M-62.11%873K-59.11%1.03M-79.49%731K-79.49%731K-67.48%1.03M
Non current liabilities
-Long term debt -84.62%4K-73.08%7K-45.00%11K-45.00%11K-36.00%16K116.67%26K85.71%26K--20K--20K--25K
Non current accrued expenses -14.08%122K-9.22%128K38.78%136K38.78%136K44.09%134K77.50%142K58.43%141K81.48%98K81.48%98K43.08%93K
Total non current liabilities 197.55%2.68M309.16%4.33M240.08%2.55M240.08%2.55M124.36%2.37M-61.18%899K-58.31%1.06M-78.93%751K-78.93%751K-66.69%1.06M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Additional paid-in capital 11.83%39.33M10.94%38.95M6.93%37.18M6.93%37.18M5.37%36.49M2.35%35.17M2.88%35.11M3.28%34.77M3.28%34.77M23.68%34.63M
Retained earnings 2.94%105K33.01%137K32.69%138K32.69%138K37.14%144K-6.42%102K1.98%103K--104K--104K36.36%105K
Other equity interest --35K------------------------------------
Total equity 47.68%8.72M41.29%9.04M-0.52%6.94M-0.52%6.94M-17.44%6.87M-37.66%5.9M-43.30%6.4M-44.52%6.98M-44.52%6.98M16.80%8.32M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg